Cott (TSE:PRM) Upgraded at William Blair

William Blair upgraded shares of Cott (TSE:PRMFree Report) to a strong-buy rating in a research report released on Thursday, Zacks.com reports.

Separately, Raymond James lowered shares of Cott from a “moderate buy” rating to a “hold” rating in a research note on Wednesday, October 2nd.

Check Out Our Latest Report on Cott

Cott Trading Up 0.1 %

TSE:PRM opened at C$13.77 on Thursday. Cott has a 12-month low of C$13.20 and a 12-month high of C$14.97.

Cott (TSE:PRMGet Free Report) last announced its earnings results on Thursday, August 8th. The company reported C$0.30 earnings per share for the quarter, missing analysts’ consensus estimates of C$0.32 by C($0.02). The company had revenue of C$663.59 million for the quarter, compared to analysts’ expectations of C$658.00 million.

Cott Dividend Announcement

The company also recently announced a None dividend, which will be paid on Thursday, November 21st. Shareholders of record on Tuesday, November 5th will be given a $1.109 dividend. The ex-dividend date is Tuesday, November 5th.

About Cott

(Get Free Report)

Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.

Featured Stories

Receive News & Ratings for Cott Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cott and related companies with MarketBeat.com's FREE daily email newsletter.